Nl. Kanagy et Gd. Fink, LOSARTAN PREVENTS SALT-INDUCED HYPERTENSION IN REDUCED RENAL MASS RATS, The Journal of pharmacology and experimental therapeutics, 265(3), 1993, pp. 1131-1136
A reduction in functioning renal mass through surgical ablation leads
to the development of hypertension and chronic renal failure in rats.
Reduced renal mass (RRM) hypertension is more severe and develops more
quickly if rats are on high salt intake. It has previously been shown
that hypertension in these rats can be prevented by treatment with an
giotensin-converting enzyme inhibitors. The current experiment examine
d the effect of losartan, an angiotensin II antagonist, on blood press
ure in RRM and intact rats after a 3-fold increase in salt intake. It
was found that chronic treatment with i.v. losartan (3 mg/kg/day) comp
letely prevented sodium-induced hypertension in the RRM rats, whereas
neither increased salt intake nor losartan treatment affected blood pr
essure in the intact rats. The antihypertensive effect of losartan was
associated with an apparent renoprotective effect in RRM rats (blood
urea nitrogen concentration rose in untreated animals, but remained st
able in treated animals), but was not accompanied by chronic changes i
n water or sodium balance. The ability of losartan to prevent RRM hype
rtension suggests that angiotensin II is necessary for the development
of this model of hypertension.